Horan Securities’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-266
Closed -$9.6K 323
2023
Q2
$9.6K Hold
266
﹤0.01% 399
2023
Q1
$10.2K Hold
266
0.01% 375
2022
Q4
$15.1K Hold
266
0.01% 325
2022
Q3
$11K Hold
266
0.01% 341
2022
Q2
$13K Hold
266
0.01% 293
2022
Q1
$11K Hold
266
0.01% 313
2021
Q4
$11K Buy
+266
New +$9.93K 0.01% 311
2021
Q2
$12K Hold
266
0.01% 283
2021
Q1
$11K Hold
266
0.01% 257
2020
Q4
$11K Hold
266
0.01% 249
2020
Q3
$7K Hold
266
0.01% 237
2020
Q2
$7K Hold
266
0.01% 211
2020
Q1
$5K Buy
+266
New +$5.05K 0.01% 169
2019
Q4
Sell
-266
Closed -$4K 109
2019
Q3
$4K Hold
266
﹤0.01% 210
2019
Q2
$5K Hold
266
0.01% 218
2019
Q1
$4K Hold
266
﹤0.01% 198
2018
Q4
$4K Hold
266
﹤0.01% 183
2018
Q3
$4K Hold
266
﹤0.01% 179
2018
Q2
$5K Hold
266
﹤0.01% 166
2018
Q1
$5K Hold
266
﹤0.01% 152
2017
Q4
$5K Hold
266
﹤0.01% 154
2017
Q3
$5K Hold
266
﹤0.01% 140
2017
Q2
$3K Hold
266
﹤0.01% 158
2017
Q1
$3K Buy
+266
New +$3.36K ﹤0.01% 157
2016
Q4
Sell
-266
Closed -$2K 75
2016
Q3
$2K Buy
+266
New +$2.72K ﹤0.01% 135

Other funds holding HALO

Horan Securities's HALO Position: Q3 2023 in Review

Horan Securities sold out of Halozyme (HALO) in Q3 2023, closing a stake of 266 shares — an estimated $9.6K sold.

Horan Securities first reported a position in HALO in Q3 2016 and held it in 25 quarters. The position peaked at $15.1K in Q4 2022. 389 funds tracked by Wall St. Rank hold HALO as of Q3 2023.

  • Horan Securities reported no remaining Halozyme position as of Q3 2023 after selling out during the quarter.
  • Horan Securities sold 266 Halozyme shares in Q3 2023, an estimated $9.6K.
  • Horan Securities first reported a position in Halozyme in Q3 2016 and held it in 25 quarters.
  • Horan Securities's Halozyme position peaked at $15.1K in Q4 2022.
  • 389 funds tracked by Wall St. Rank held Halozyme as of Q3 2023.

Based on Horan Securities's 13F filing for Q3 2023, filed 1 Nov 2023.